Taurox™
-
Double-Blind Placebo-Controlled Trials
-
Scientific Background on Taurox™
-
Clinical Data and Experience on Taurox™
Allergies Hay fever Asthma Hepatitis Cancer Infections Cold & Flu Lyme Disease EPO Benefits & Dangers Lymphoma Fatigue Pet Health Fatigue Syndromes Waldenstrom's Fibromyalgia Post Marketing Study
Double-Blind Placebo-Controlled Trials
The initial study of 39 patients was double-blind and placebo-controlled. 92% of those receiving Taurox™ had physiological effects, 26% of patients receiving placebo had physiological effects. These data were highly statistically significant.